Parametric Portfolio Associates’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-42,209
| Closed | -$796K | – | 4056 |
|
|
2019
Q3 | $796K | Sell |
42,209
-19,806
| -32% | -$374K | ﹤0.01% | 3144 |
|
|
2019
Q2 | $730K | Buy |
62,015
+456
| +0.7% | +$5.37K | ﹤0.01% | 3200 |
|
|
2019
Q1 | $840K | Buy |
61,559
+1,842
| +3% | +$25.1K | ﹤0.01% | 3107 |
|
|
2018
Q4 | $612K | Sell |
59,717
-2,622
| -4% | -$26.9K | ﹤0.01% | 3223 |
|
|
2018
Q3 | $1.04M | Sell |
62,339
-2,476
| -4% | -$41.2K | ﹤0.01% | 3068 |
|
|
2018
Q2 | $1.02M | Buy |
64,815
+3,793
| +6% | +$59.9K | ﹤0.01% | 3046 |
|
|
2018
Q1 | $775K | Sell |
61,022
-8,782
| -13% | -$112K | ﹤0.01% | 3137 |
|
|
2017
Q4 | $799K | Buy |
69,804
+35,610
| +104% | +$408K | ﹤0.01% | 3124 |
|
|
2017
Q3 | $419K | Sell |
34,194
-10,866
| -24% | -$133K | ﹤0.01% | 3518 |
|
|
2017
Q2 | $516K | Buy |
45,060
+25,425
| +129% | +$291K | ﹤0.01% | 3352 |
|
|
2017
Q1 | $408K | Sell |
19,635
-7,747
| -28% | -$161K | ﹤0.01% | 3295 |
|
|
2016
Q4 | $570K | Sell |
27,382
-38,987
| -59% | -$812K | ﹤0.01% | 3127 |
|
|
2016
Q3 | $2.18M | Sell |
66,369
-1,135
| -2% | -$37.2K | ﹤0.01% | 2280 |
|
|
2016
Q2 | $1.69M | Buy |
67,504
+26,767
| +66% | +$669K | ﹤0.01% | 2444 |
|
|
2016
Q1 | $998K | Buy |
40,737
+27,072
| +198% | +$663K | ﹤0.01% | 2933 |
|
|
2015
Q4 | $451K | Buy |
+13,665
| New | +$451K | ﹤0.01% | 3320 |
|